A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

June 30, 2006

Conditions

Colorectal Cancer

Interventions

DRUG

Gefitinib, raltitrexed

Trial Locations (9)

Research Site, A Coruña

Research Site, Barcelona

Research Site, Burgos

Research Site, Gijón

Research Site, León

Research Site, Madrid

Research Site, Oviedo

Research Site, Pamplona

Research Site, Valladolid